首页> 外国专利> Implantable cellular therapy device for treatment of graft versus host disease and tolerance induction

Implantable cellular therapy device for treatment of graft versus host disease and tolerance induction

机译:用于治疗移植物抗宿主疾病和耐受性诱导的植入式细胞治疗装置

摘要

Implantable devices comprising a scaffold, cells, and/or therapeutic molecules are provided. Uses include inhibition of pathological immunity, elaboration of therapeutic growth factors, and immune augmentation. The implantable device may contain a porous substrate structure to which therapeutic cells are adherent, which can be implanted and explanted from a patient. In another embodiment, a medical device includes a porous substrate seeded with therapeutic cells, said device comprising of an additional layer allowing free exchange of molecules without cell escape. Said medical device is seeded with thymic medullary epithelial cells or progenitors of said thymic medullary epithelial cells. In conditions where tolerance to alloreactive donor cells is desired, the thymic medullary epithelial cells or progenitors thereof are derived from recipient cells. In conditions where tolerance to alloreactive recipient cells is desired, the thymic medullary epithelial cells or progenitors thereof are derived from donor cells.
机译:提供了包括支架,细胞和/或治疗分子的可植入装置。用途包括抑制病理免疫力,制定治疗性生长因子和增强免疫力。可植入装置可包含粘附有治疗细胞的多孔基底结构,其可被植入患者体内或从患者体内植入。在另一个实施方案中,医疗装置包括接种有治疗性细胞的多孔基质,所述装置包括允许分子自由交换而不使细胞逃逸的附加层。所述医疗装置被接种有胸腺髓质上皮细胞或所述胸腺髓质上皮细胞的祖细胞。在需要对同种反应性供体细胞耐受的条件下,胸腺髓质上皮细胞或其祖细胞衍生自受体细胞。在需要对同种反应性受体细胞具有耐受性的条件下,胸腺髓质上皮细胞或其祖细胞衍生自供体细胞。

著录项

  • 公开/公告号US10532128B2

    专利类型

  • 公开/公告日2020-01-14

    原文格式PDF

  • 申请/专利权人 VIERA BIOSCIENCE INC.;

    申请/专利号US201615353600

  • 发明设计人 THOMAS ICHIM;

    申请日2016-11-16

  • 分类号A61L27/56;A61L27/38;C12N5;A61M5/142;

  • 国家 US

  • 入库时间 2022-08-21 11:29:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号